Simvastatin tablets recalled due to manufacturing process deviations
Accord Healthcare is recalling Simvastatin 10 mg tablets distributed in the U.S., Puerto Rico, and Canada due to manufacturing process deviations discovered during FDA inspection. Patients should contact their pharmacy or healthcare provider.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses, injuries, or deaths. The hazard consists of manufacturing process deviations identified during FDA inspection. Per the rubric, when no illnesses or injuries are reported and the hazard is theoretical, the score is at most 3. The precautionary nature of this quality control-based recall places it at Moderate (2).
Plain-English summary
Accord Healthcare, Inc. is recalling Simvastatin 10 mg tablets distributed in the United States, Puerto Rico, and Canada. The recall involves approximately 291,378 bottles in 90-count and 1,000-count packages across multiple batches.
The recall was initiated following an FDA inspection that identified deviations from Current Good Manufacturing Practice (CGMP) requirements. The specific nature of these deviations is not detailed in the available recall information.
Consumers with affected medication should contact their pharmacy or healthcare provider to determine if their specific batch is impacted. Patients should not discontinue their medication without consulting their healthcare provider.
Affected batch numbers and expiration dates can be obtained from the recalling company. Consumers should not discard their medication without professional guidance.
The recalled product
- Product
- SIMVASTATIN (SIMVASTATIN)
- Brand
- SIMVASTATIN
- Manufacturer
- Accord Healthcare, Inc.
- Category
- Drug — Prescription Statin
- Hazard
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Batches: a) P2106923
- Exp. Date 9/30/2023
- R2101544
- Exp. Date 10/31/2023
- R2200732
- Exp. Date 5/31/2025
- b) P2101634
- Exp. Date 2/28/2023
- P2102370
- Exp. Date 3/31/2023
- P2102321
- P2102411
- P2102454
- P2103991
- Exp. Date 5/31/2023
- R2100954
- Exp. Date 6/30/2023
- R2100947
- R2100951
- P2106242
UPCs (2)
- 316729004152
- 316729004176
Distribution
Distribution scope not specified by the agency.
Related recalls
Same brand · SIMVASTATIN
- HighSimvastatin 40 mg tablets recalled for manufacturing practice deviations
FDA (Drugs) · 2023-03-08
- HighPrescription Drug Simvastatin Recalled for Manufacturing Deviations
FDA (Drugs) · 2023-03-08
- ModerateSimvastatin Tablets Recalled Due to Manufacturing Practice Deviations
FDA (Drugs) · 2023-03-08
- HighAccord Healthcare Simvastatin 80 mg Tablets Recalled for Manufacturing Practice Violations
FDA (Drugs) · 2023-03-08
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27